Resources
Stay up-to-date with the latest news, articles, and industry insights from VigiLanz.
Filter By:
Antimicrobial Stewardship Spotlight Findings
The Hospital Patient Safety Report serves as a barometer of safety performance within U.S. hospitals. Based on an annual survey of 100 hospital executives and clinical leaders, the report reveals how safety challenges, initiatives, and priorities are evolving.
Enhancing Patient Safety Saves Hospitals Millions: Learn How Much Yours Could Save
This is no time for hospitals to hit the brakes on patient safety improvements.
Technology Can Help with Vancomycin Dosing
Pharmacy Practice News recently interviewed Houston Methodist Hospital about how they are using VigiLanz precision dosing powered by DoseMeRx to gain instant access to personalized dosing for vancomycin and other antimicrobials.
Economic Value Tool – Calculate Your Savings
See how your hospital or health system could be using VigiLanz to save millions by optimizing efficiency and improving patient safety.
Hospital Patient Safety Report: Antimicrobial Stewardship
To better understand the state of hospital patient safety and the biggest opportunities for improvement, VigiLanz commissioned Sage Growth Partners, a healthcare consultancy, to conduct an independent survey of 100 hospital and health system leaders in February 2020.
VigiLanz Ranked No. 1 by KLAS Research Across Three Categories for the Third Year
Clinical surveillance company recognized again as a KLAS leader in antimicrobial stewardship, infection control and monitoring, and pharmacy surveillance
IllumiCare and VigiLanz Partner to Help Pharmacists and Clinicians Advance Antimicrobial Stewardship
Houston Methodist Sugar Land Hospital first in country to launch new point-of-care alert solution with pharmacist-only rollout.
VigiLanz Ranked No. 1 by KLAS Research for Antimicrobial Stewardship, Infection Control and Monitoring, and Pharmacy Surveillance
VigiLanz, a clinical surveillance company, today announced that it has earned 2019 Category Leader designations from KLAS Research for Antimicrobial Stewardship, Infection Control and Monitoring, and Pharmacy Surveillance.
VigiLanz Platform Earns Meaningful Use Stage 3 Certification for Antimicrobial Use and Resistance Reporting
VigiLanz, a digital healthcare intelligence firm, announced today that its antimicrobial stewardship platform has earned Meaningful Use Stage 3 (MU3) certification validating its ability to collect and properly report data around antimicrobial use and resistance.